Jean Mantz, MD, PhD discussed new insights in ICU sedation. The goals of ICU sedation have changed from providing deep sedation to alleviating sedation to improve outcomes. Overly deep sedation can contribute to increased ventilation time and length of stay, and impair neurological examination and cognition. The ICU environment, including sedation, can negatively impact brain function by causing delirium, sleep disorders, and long-term cognitive impairment. Dexmedetomidine is a short-acting sedative and analgesic that maintains arousability while reducing the detrimental effects of other sedatives. It may play a major role in ensuring cooperative sedation in the ICU.